What is the recommended dosing for fluoxetine (Selective Serotonin Reuptake Inhibitor - SSRI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fluoxetine Dosing Recommendations

For adults with depression, the recommended starting dose of fluoxetine is 20 mg once daily in the morning, with potential dose increases up to a maximum of 80 mg/day if needed. 1

Initial Dosing for Different Conditions

Major Depressive Disorder

  • For adults: Start with 20 mg/day administered in the morning 1
  • For children and adolescents: Start with 10 mg/day (especially for lower weight children) or 20 mg/day; after 1 week at 10 mg/day, the dose can be increased to 20 mg/day 1
  • Dose increases above 20 mg/day may be considered after several weeks if insufficient clinical improvement is observed 1
  • Maximum recommended dose is 80 mg/day 1

Obsessive-Compulsive Disorder (OCD)

  • For adults: Start with 20 mg/day in the morning 1
  • For adolescents and higher weight children: Start with 10 mg/day, increase to 20 mg/day after 2 weeks 1
  • For lower weight children: Start with 10 mg/day, with a recommended dose range of 20-30 mg/day 1
  • Dose range for adults and higher weight children: 20-60 mg/day 1
  • Maximum dose should not exceed 80 mg/day 1

Bulimia Nervosa

  • Recommended dose is 60 mg/day, administered in the morning 1
  • For some patients, it may be advisable to titrate up to this target dose over several days 1

Panic Disorder

  • Start with 10 mg/day 1
  • After 1 week, increase to 20 mg/day 1
  • Most frequently used dose in clinical trials was 20 mg/day 1
  • Maximum studied dose is 60 mg/day 1

Special Considerations

Pharmacokinetics and Administration Timing

  • Fluoxetine has a very long half-life (1-3 days for fluoxetine, 4-16 days for its active metabolite norfluoxetine) 2
  • Due to its activating properties, morning dosing is preferred to avoid insomnia 2
  • Side effects may not appear immediately but can develop over several weeks of treatment due to the long half-life 2

Dose Adjustments for Special Populations

  • Lower or less frequent dosing should be used in patients with hepatic impairment 1
  • Lower or less frequent dosing should be considered for elderly patients 1
  • Dosage adjustments for renal impairment are not routinely necessary 1

Maintenance Treatment

  • For major depressive disorder, efficacy is maintained for periods up to 38 weeks following 12 weeks of open-label acute treatment at 20 mg/day 1
  • Weekly dosing with Prozac Weekly (once weekly) can be initiated 7 days after the last daily dose of Prozac 20 mg for maintenance treatment 1

Managing Treatment Failure

  • If a patient relapses on 20 mg/day, increasing the dose to 40 mg/day can be effective, with studies showing 67% of patients achieving full response after dose increase 3
  • Higher daily doses of fluoxetine (40 mg) have shown reduced relapse rates compared to lower doses (20 mg) 4

Potential Adverse Effects

  • Common side effects include insomnia, asthenia, somnolence, decreased libido, and gastrointestinal disturbances 5
  • Fluoxetine should be used with caution in patients with congenital long QT syndrome, previous history of QT prolongation, or family history of long QT syndrome 6
  • CYP2D6 poor metabolizers may experience higher plasma concentrations and potentially more side effects 6

Drug Interactions and Precautions

  • At least 14 days should elapse between discontinuation of an MAOI and initiation of therapy with fluoxetine 1
  • At least 5 weeks should be allowed after stopping fluoxetine before starting an MAOI 1
  • When switching to a tricyclic antidepressant (TCA), the dosage of the TCA may need to be reduced and plasma TCA concentrations may need to be monitored 1

By following these dosing recommendations and considering individual patient factors, clinicians can optimize the therapeutic benefits of fluoxetine while minimizing potential adverse effects.

References

Guideline

Fluoxetine Titration and Dosage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Fluoxetine once every third day in the treatment of major depressive disorder.

European archives of psychiatry and clinical neuroscience, 2003

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.